Clinical Trials Directory

Trials / Completed

CompletedNCT07386288

Short-term Perfusion Effects: Dexketoprofen/Tramadol

Short-term Effects of Intravenous Dexketoprofen Trometamol and Tramadol on Perfusion-Related Physiological Parameters in Renal Colic

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
102 (actual)
Sponsor
Ataturk University · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Background: Acute renal colic is a common reason for admission to the emergency department (ED) and is associated with severe pain, sympathetic activation and metabolic stress. Non-steroidal anti-inflammatory drugs (NSAIDs) and opioids are widely used for analgesia, but their short-term effects on tissue perfusion and respiratory physiology in stable patients are unclear. End-tidal carbon dioxide (EtCO₂) has been suggested as a non-invasive indicator of overall tissue perfusion, but how it behaves during analgesic treatment in stable ED patients is unclear. Methods: This prospective, randomised study was conducted in an academic emergency department. Adult patients (aged 18-55) presenting with acute renal colic were randomised to receive an intravenous infusion of either dexketoprofen trometamol (50 mg), tramadol (100 mg), or a combination of dexketoprofen trometamol (50 mg) and tramadol (50 mg). Vital signs, oxygen saturation (SpO₂) and EtCO₂ were recorded at baseline and at 30 and 60 minutes. Arterial blood gas parameters, including lactate, were measured at baseline and after 60 minutes. The primary outcome was the change in EtCO₂ over time.

Conditions

Interventions

TypeNameDescription
DRUGTramadolIntravenous tramadol administered for analgesia in patients with renal colic.
DRUGDexketoprofen TrometamolIntravenous dexketoprofen trometamol administered for analgesia in patients with renal colic
DRUGIV Tramadol + IV Dexketoprofen TrometamolIntravenous dexketoprofen trometamol and tramadol administered for analgesia in patients with renal colic

Timeline

Start date
2024-11-01
Primary completion
2025-04-30
Completion
2025-04-30
First posted
2026-02-04
Last updated
2026-02-04

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07386288. Inclusion in this directory is not an endorsement.

Short-term Perfusion Effects: Dexketoprofen/Tramadol (NCT07386288) · Clinical Trials Directory